Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-06-06

Clinical Trial Update: Safety and Efficacy of Valsartan vs Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing valsartan to the combination of atenolol and hydrochlorothiazide in hypertensive patients; results regarding safety and efficacy on bloo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atenolol (Atenolol)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Valsartan (Diovan) (Valsartan)

Snippet

Sponsor: Novartis | Conditions: Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-06-06